|
Volumn 103, Issue 17, 2011, Pages 1286-1288
|
Oral contraceptives as ovarian cancer prevention.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
ORAL CONTRACEPTIVE AGENT;
CLINICAL TRIAL (TOPIC);
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
META ANALYSIS (TOPIC);
NOTE;
OVARY TUMOR;
TIME;
TREATMENT OUTCOME;
ANTICARCINOGENIC AGENTS;
CANCER VACCINES;
CLINICAL TRIALS AS TOPIC;
CONTRACEPTIVES, ORAL, HORMONAL;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
META-ANALYSIS AS TOPIC;
OVARIAN NEOPLASMS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 80155192619
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr341 Document Type: Note |
Times cited : (3)
|
References (0)
|